Basic Information
| LncRNA/CircRNA Name | SNHG14 |
| Synonyms | NA |
| Region | GRCh38_15:24978583-25419462 |
| Ensemble | ENSG00000224078 |
| Refseq | NR_146177 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | prostate cancer |
| ICD-0-3 | C61.9 |
| Methods | RT-qPCR, RIP |
| Sample | prostate cancer tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | cell proliferation was inhibited after SNHG14 was silenced in prostate cancer cells and the expression of miR-613 was upregulated after SNHG14 was silenced. Further mechanism assays showed that miR-613 was a direct target of SNHG14 in prostate cancer. |
| Pubmed ID | 32016964 |
| Year | 2020 |
| Title | Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613 |
External Links
| Links for SNHG14 | GenBank HGNC NONCODE |
| Links for prostate cancer | OMIM COSMIC |